C-peptide is inversely associated with glycaemic variability and post-meal glucose rise in both Type 1 and Type 2 diabetes (16) and is inversely associated with response to prandial insulin in experimental conditions in a mixed population with diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.